Adma Biologics Inc [NASDAQ: ADMA] traded at a high on 2025-06-26, posting a 4.55 gain after which it closed the day’ session at $3520000.0.
The results of the trading session contributed to over 4467401 shares changing hands. Over the past one week, the price volatility of Adma Biologics Inc stands at 3.48% while the volatility over the past one month is 4.18%.
The market cap for ADMA stock reached $4.39 billion, with 238.53 million shares outstanding and 230.52 million shares in the current float. Compared to the average trading volume of 3.52M shares, ADMA reached a trading volume of 4467401 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Adma Biologics Inc [ADMA]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ADMA shares is $32.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ADMA stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Raymond James have made an estimate for Adma Biologics Inc shares, keeping their opinion on the stock as Strong Buy, with their previous recommendation back on July 19, 2023. While these analysts kept the previous recommendation, Mizuho raised their target price to Buy. The new note on the price target was released on October 13, 2022, representing the official price target for Adma Biologics Inc stock. Previously, the target price had yet another raise to $5, while Raymond James analysts kept a Strong Buy rating on ADMA stock.
The Price to Book ratio for the last quarter was 11.75, with the Price to Cash per share for the same quarter was set at 0.30. Price to Free Cash Flow for ADMA in the course of the last twelve months was 48.46 with Quick ratio for the last quarter at 3.36.
How has ADMA stock performed recently?
Adma Biologics Inc [ADMA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.49. With this latest performance, ADMA shares dropped by -7.49% in over the last four-week period, additionally plugging by 5.75% over the last 6 months – not to mention a rise of 7.29% in the past year of trading.
Adma Biologics Inc [ADMA]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Adma Biologics Inc [ADMA] shares currently have an operating margin of 33.10% and a Gross Margin at 52.53%. Adma Biologics Inc’s Net Margin is presently recorded at 45.01%.
Return on Equity for this stock inclined to 48.01%, with Return on Assets sitting at 48.01%.
Earnings analysis for Adma Biologics Inc [ADMA]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ADMA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Adma Biologics Inc go to 39.37%.
Insider trade positions for Adma Biologics Inc [ADMA]
The top three institutional holders of ADMA stocks are: BLACKROCK INC. with ownership of 18.64 million shares, which is approximately 8.0221%. VANGUARD GROUP INC, holding 14.52 million shares of the stock with an approximate value of $$162.3 million in ADMA stocks shares; and VANGUARD GROUP INC, currently with $$147.25 million in ADMA stock with ownership which is approximately 5.6668%.
